Avanos Medical (AVNS) Cash from Operations (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Cash from Operations data on file, last reported at 12300000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 147.86% year-over-year to 12300000.0; the trailing twelve-month figure through Mar 2026 stood at 36700000.0 (down 72.69% YoY), and the FY2025 full-year result was 74700000.0, down 25.82% from the prior year.
• Cash from Operations retreated to 12300000.0 in Q1 2026, from 28200000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 57900000.0 in Q4 2024 to a low of 12300000.0 in Q1 2026.
• A 5-year average of 16847058.82 and a median of 23000000.0 in 2024 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations slumped 477.78% in 2023 and surged 1169.23% in 2024, its largest moves.
• Tracing AVNS's Cash from Operations over 5 years: stood at 33700000.0 in 2022, then slumped by 62.31% to 12700000.0 in 2023, then jumped by 355.91% to 57900000.0 in 2024, then sank by 51.3% to 28200000.0 in 2025, then tumbled by 143.62% to 12300000.0 in 2026.
• Business Quant data shows AVNS's Cash from Operations at 12300000.0 in Q1 2026, 28200000.0 in Q4 2025, and 14000000.0 in Q3 2025.